T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Fortinet
FTNT
|
$2.09B |
| 2 |
Rockwell Automation
ROK
|
$1.46B |
| 3 |
Autodesk
ADSK
|
$1.19B |
| 4 |
Citigroup
C
|
$1.11B |
| 5 |
ConocoPhillips
COP
|
$1.08B |
Top Sells
| 1 |
NVIDIA
NVDA
|
$3.23B |
| 2 |
GE Aerospace
GE
|
$2.12B |
| 3 |
Alphabet (Google) Class C
GOOG
|
$1.46B |
| 4 |
Meta Platforms (Facebook)
META
|
$1.17B |
| 5 |
Philip Morris
PM
|
$1.06B |
Sector Composition
| 1 | Technology | 32.25% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.37% |
| 5 | Communication Services | 8.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Willamette Valley Vineyards
WVVI
$24.3M
| $55K | ﹤0.01% |
10,850
| – | – |
|
2852
X4 Pharmaceuticals
XFOR
$78.6M
| $55K | ﹤0.01% |
1,310
+417
| +47% | +$17.5K |
|
2853
Harvard Bioscience
HBIO
$21.3M
| $54K | ﹤0.01% |
+12,624
| New | +$54K |
|
2854
Ovid Therapeutics
OVID
$87.5M
| $54K | ﹤0.01% |
17,396
+3,145
| +22% | +$9.76K |
|
2855
WideOpenWest
WOW
$441M
| $53K | ﹤0.01% |
14,616
+2,732
| +23% | +$9.91K |
|
|
PHLT
2856
Performant Healthcare, Inc. Common Stock
PHLT
$603M
| $53K | ﹤0.01% |
18,015
+452
| +3% | +$1.33K |
|
2857
CEL-SCI Corp
CVM
$72.2M
| $52K | ﹤0.01% |
893
| – | – |
|
2858
Erasca
ERAS
$457M
| $51K | ﹤0.01% |
24,684
+4,753
| +24% | +$9.82K |
|
2859
Nerdy
NRDY
$163M
| $51K | ﹤0.01% |
17,248
+2,923
| +20% | +$8.64K |
|
|
PPTA
2860
Perpetua Resources
PPTA
$1.98B
| $51K | ﹤0.01% |
+12,049
| New | +$51K |
|
2861
Rafael Holdings
RFL
$50.5M
| $51K | ﹤0.01% |
29,731
| – | – |
|
2862
Humacyte
HUMA
$226M
| $50K | ﹤0.01% |
15,853
+405
| +3% | +$1.28K |
|
2863
BARK
BARK
$149M
| $49K | ﹤0.01% |
39,225
+8,436
| +27% | +$10.5K |
|
|
SAVAW
2864
DELISTED
Cassava Sciences, Inc. Warrant
SAVAW
| $49K | ﹤0.01% |
+11,944
| New | +$49K |
|
2865
Compass Therapeutics
CMPX
$590M
| $48K | ﹤0.01% |
24,055
+700
| +3% | +$1.4K |
|
2866
Nautilus Biotechnolgy
NAUT
$83.5M
| $48K | ﹤0.01% |
16,078
+4,239
| +36% | +$12.7K |
|
2867
Ampco-Pittsburgh
AP
$55.9M
| $47K | ﹤0.01% |
21,600
| – | – |
|
2868
PEDEVCO
PED
$56.6M
| $47K | ﹤0.01% |
57,500
| – | – |
|
2869
Trevi Therapeutics
TRVI
$854M
| $47K | ﹤0.01% |
+13,561
| New | +$47K |
|
|
SRTA
2870
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$332M
| $46K | ﹤0.01% |
15,821
+566
| +4% | +$1.65K |
|
2871
Eos Energy Enterprises
EOSE
$2.01B
| $46K | ﹤0.01% |
43,930
+18,735
| +74% | +$19.6K |
|
2872
BioAtla
BCAB
$31.5M
| $45K | ﹤0.01% |
+12,791
| New | +$45K |
|
2873
Design Therapeutics
DSGN
$367M
| $45K | ﹤0.01% |
+11,147
| New | +$45K |
|
2874
FTC Solar
FTCI
$93.4M
| $45K | ﹤0.01% |
8,165
| – | – |
|
2875
Information Services Group
III
$253M
| $45K | ﹤0.01% |
+10,949
| New | +$45K |
|